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Abstract
Background: Type 2 Diabetes Mellitus (T2DM) is associated with diabetic nephropathy and hyperlipidemia. Gender, age, med-
ication adherence, lifestyle, culture and socioeconomic status could be sources of  diversity in T2DM leading to differences in 
predisposition, development and clinical presentation. 
Objectives: Therefore, this study aimed to investigate the influence of  gender, age and treatment duration on kidney and lip-
id-related biochemical indices of  T2DM patients attending Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria (EK-
SUTH).
Methods: Blood from diabetic patients and healthy subjects was analysed for fasting blood glucose (FBG), renal function 
parameters and lipid profile. Influence of  age, gender and treatment duration on indices was assessed using standard baseline 
values.  
Results: Dyslipidemia was pronounced among female diabetics while the incidence of  diabetes was found to be higher in mid-
dle-age. The percentage of  diabetics with high levels of  FPG, urea, creatinine, cholesterol, triglyceride and low density lipopro-
tein-cholesterol after 9-10 years of  treatment were lower compared with the percentage after 5-6 years of  treatment. 
Conclusion: Gender, age and treatment duration influenced clinical course of  T2DM among patients presenting at EKSUTH 
but long term treatment appeared to improve T2DM among patients.
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Diabetes mellitus (DM) is estimated to affect 2.8% of  
the world’s population at present and projected to cross 
5.4% mark by 20251. The International Diabetes Federa-
tion (IDF) estimated that in 2011 there were 366 million 
people with diabetes and this was expected to rise to 552 
million by 20302.  According to IDF atlas (2012) the prev-
alence rate of  diabetes in Africa is 4.3%, while 81.2% of  
cases remain undiagnosed. Africa has the highest mor-
tality rate due to diabetes and over the next 20 years, the 
number of  people with diabetes in Africa will almost 
double. Diabetes is considered a syndrome because of  
the many symptoms the individuals present with especial-
ly if  management is not adhered to3,4. Lack of  insulin or 
relatively low insulin levels affects the metabolism of  car-
bohydrate, protein, fat, water and electrolyte balance re-
sulting in diabetes5,6. The prevalence of  T2DM increases 
with age such that in developing countries, most diabetics 
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are in the age group of  45 to 64 years, while in developed 
countries the largest number is found in those aged 65 
years and above7,8. 
The major risk factors for T2DM are obesity (>120% 
ideal body weight or a body mass index >30 kg/m2) and 
a sedentary lifestyle9,10. In T2DM lipid abnormalities 
are almost the rule. Typical findings are elevation of  to-
tal and VLDL-C cholesterol, triglyceride concentration, 
lowering of  HDL-C cholesterol and a predominance of  
small, dense LDL-C particles11. Insulin resistance is of-
ten involved in this process12 though the pathophysiol-
ogy of  lipid abnormalities in diabetes is not yet totally 
explained. Urea and creatinine levels are also affected in 
diabetes. During dehydration urea clearance is decreased 
and more is reabsorbed causing an increase in blood urea 
level. Urea and creatinine are the parameters to diagnose 
functioning of  the kidney. However, changes in serum 
creatinine concentration more reliably reflect changes in 
glomerular filtration rate (GFR) than do changes in se-
rum urea concentrations13. 
There is no uniform view on the influence of  age and 
gender on T2DM among researchers. It has been report-
ed that T2DM is more frequently diagnosed at lower age 
and body mass index in men whereas the most prom-
inent risk factor, which is obesity, is more common in 
women14. Another study associated the higher prevalence 
of  T2DM in older men than in older women with larg-
er amount of  visceral fat in men15. However, a previous 
study showed that among Zuni Indians, the prevalence of  
diabetes was higher in females than males16. It has been 
observed that there is wide sex-ratio diversity in T2DM 
across countries leading to differences in predisposition, 
development and clinical presentation and, the differ-
ences between males and females could be influenced by 
culture, lifestyle and socioeconomic status14,16. Therefore, 
the objectives of  this study were to determine the fast-
ing blood glucose (FBG), lipid profile, urea and creati-
nine levels as well as derived cardiovascular risk factors in 
T2DM patients attending Ekiti State University Teaching 
Hospital, Ado-Ekiti, Nigeria (EKSUTH) and examine 
the effect of  sex, age, and duration of  treatment on the 
studied parameters. This could provide valuable insights 
that will assist health professionals in providing better 
treatment and help researchers in evolving more effective 
approaches in antidiabetic investigations. 
Subjects and methods  
Experimental design and sample collection
A total of  106 known T2DM and 40 normal subjects of  
both sexes, aged between 30 years and 90 years attending 
the medical outpatients department of  EKSUTH were 
screened and used for the study. Ethical clearance for 
the study was approved by the ethical committee of  EK-
SUTH (EKSUTH/A67/2013/01/03) and the research 
conformed to the World Medical Association declaration 
of  Helsinki regarding ethical conduct of  research involv-
ing human subjects and/or animals. Information from 
medical records was used to confirm the T2DM status of  
subjects. Informed consent was obtained from patients 
who participated in the study. Information on age, gen-
der, cigarette smoking, duration of  diabetes, socioeco-
nomic status and family history of  coronary heart disease 
was obtained through a questionnaire administered by 
interviewers. Patients who were very ill or on admission 
were excluded from the study. Patients with chronic dis-
eases, history of  cardiovascular incidents and using drugs 
for hypertension were also excluded from the study. The 
criteria for choosing controls was fasting blood glucose 
≤7.0 mmol/L and systolic blood pressure values ≤140 
mmHg. 
Fasting venous blood sample was collected from each 
subject (both tests and controls) into fluoride oxalate 
containers (for glucose determination) and lithium hep-
arin sample containers (for lipid profile, urea and cre-
atinine determination). Each blood sample was mixed 
gently and spun as quickly as possible at 3000 rpm for 
5 min. Plasma was extracted into plain tubes and stored 
at -4°C for further analyses. Fasting blood glucose, plas-
ma urea, creatinine and lipid profile assay comprising of  
plasma triglycrides (TRIG), Total Cholesterol (CHOL), 
and High-density Lipoprotein cholesterol (HDL-C) were 
performed by methods based on enzymatic determina-
tion using kits obtained from Randox Laboratories Ltd. 
(United Kingdom). Low-density Lipoprotein cholesterol 
(LDL-C) was calculated from Friedewald formula. CHOL 
is a measure of  the cholesterol components: LDL-C, 
HDL-C and Very Low-density Lipoprotein cholesterol 
(VLDL-C). Reference range for FPG and urea are 4.1-
5.9 mmol/L and 2.1-7.1 mmol/L, respectively17. The ref-
erence range for creatinine is 62-115 mmol/L for males 
and 53-97 mmol/L in females.17 Target levels (mmol/L) 
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for CHOL, LDL-C, and TRIG are < 5.17, 2.58 and 1.69, 
respectively while the risk levels are > 6.20, 4.13 and 2.26, 
respectively. The reference range for HDL-C is 1.03-1.55 
mmol/L18. Dyslipidemia, which is a disorder of  lipopro-
tein metabolism and a condition of  an abnormal level 
and proportion of  lipids in the blood, was assessed in 
subjects through comparison of  lipid levels of  patients 
with reference values. Derived cardiovascular risk factors 
such as the atherogenic index of  plasma are predictive 
of  the risk of  atherosclerosis and coronary heart disease.
Statistical analysis
Statistical analysis of  the data generated was performed 
with computer software, Statistical Package for Social Sci-
ences (SPSS) version 16.0. Values were expressed as mean 
± standard deviation (SD). The data was analyzed using 
Analysis of  variance (ANOVA) and Student’s t-test. P < 
0.05 was considered significant.
Results
Subjects in this study were of  Yoruba ethnicity and a mix-
ture of  those who had formal education and those who 
did not. Most of  the diabetic patients were on DM foods 
like beans, unripe plantain and fruits.
A significantly higher fasting blood glucose (p<0.0001), 
creatinine (p<0.0001) and urea (p<0.0455) levels were 
observed in the diabetic group when compared with the 
controls (Figure 1). 
 
 
Figure 1. Fasting blood glucose, creatinine and urea levels in 
controls and diabetics. Results are presented as mean ± SD (n = 40 for 
control and 106 for diabetics). Diabetics showed significantly higher levels 
of the measured indices than the control subjects. FBG: Fasting blood glucose. 
In addition, the diabetic group showed significantly high-
er TRIG (p<0.0001) and LDL-C (p<0.009) but lower 
HDL-C (p<0.0001) levels compared with normal sub-
jects (Figure 2). Cholesterol level in diabetics was also 
slightly higher than in control (P > 0.05).
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Figure 2. Lipid profile of control and diabetic groups. Results  
are presented as mean ± SD (n = 40 for control and 106 for diabetics). 
Values for TRIG, HDL-C and LDL-C in diabetics were significantly different  
from those of controls. Diabetic CHOL was not significantly different from control.  
TRIG: triglycerides; CHOL: total cholesterol; HDL-C: High-density lipoprotein  
cholesterol; LDL-C: Low-density lipoprotein cholesterol. 
The derived cardiovascular risk factors are presented 
in Figure 3. CHOL/HDL-C, LDL-C/HDL-C, TRIG/
HDL-C and the atherogenic index of  plasma (AIP) were 
all higher in diabetics compared to normal subjects. Cho-
lesterol/HDL-C ratio, LDL-C/HDL-C ratio, TRIG/
HDL-C ratio and the atherogenic index of  plasma for the 
diabetic group were 4.89±0.66, 6.28±0.60, 0.68±0.69 and 
0.25±0.24, respectively compared with the correspond-
ing values for the control group: 3.23±0.51, 3.88±0.45, 
1.78±.57 and -0.1682±0.16, respectively (P < 0.0001). 
 
 
Figure 3. Derived predictors of cardiovascular risk. Results are presented as mean  
± SD (n = 40 for control and 106 for diabetics). Values for diabetics are significantly  
different from corresponding control values for all indices (P < 0.0001). CHOL: total  
cholesterol; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density  
lipoprotein cholesterol; TRIG: triglycerides; AIP: atherogenic index of plasma. 
Table 1 showed that among the measured indices in 
both control and diabetic groups, gender difference was 
observed only in CHOL and LDL-C levels in diabetics 
where significantly higher values (P < 0.05) were record-
ed in females (4.67±1.52 mmol/dl and 3.69±1.54 mmol/
dl) than in males (3.99±1.32 mmol/dl and 2.96±1.36 
mmol/dl), respectively. 
This implies that CHOL and LDL-C values were, respec-
tively 19% and 25% higher in female diabetics when com-
pared with male diabetics.
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FBG  4.54±0.64 4.75±0.16 0.366 6.58±0.99 7.3±1.02 0.330 
Urea 4.78±0.34 4.59±0.3 0.669 5.14±0.23 5.65±0.33 0.393 
Creatinine 72.08±1.34 77.34±1.40 0.266 85.08±1.16 100.73±2.29 0.299 
Triglycerides 0.79±0.09 0.71±0.07 0.435 1.15±0.06 1.32±0.13 0.213 
Cholesterol 4.11±0.15 4.32±0.11 0.485 3.99±0.32 4.67±0.52 0.046 
HDL-C 1.14±0.10 1.07±0.05 0.614 0.79±0.34 0.69±0.07 0.249 
LDL-C 2.58±0.18 2.98±0.16 0.165 2.96±0.36 3.69±0.54 0.037 
 
Values are presented as means ± SD, n is as shown in parenthesis. P < 0.05 implies significant difference between 
values for control or diabetics in a row. 
Figure 4 shows the percentage of  subjects in the diabetics 
group that presented with high levels of  the measured pa-
rameters with respect to the reference values. The graph 
was plotted by making the subjects presenting with values 
higher than reference values for biochemical parameters 
in each age group a percentage of  the total subjects in 
that age group. 
 
 
Figure 4. Percentage of diabetics showing high levels of measured parameters  
in various age groups. Highest percentage of diabetics with high levels of  
measured parameters was in the 50-59 year group. FBG: Fasting blood  
glucose; LDL-C: Low-density lipoprotein cholesterol. 
We observed that the 50-59 age groups had the highest 
percentage of  subjects that presented with high levels of  
most of  the parameters evaluated in this study. The per-
centage of  diabetics presenting with high levels of  fast-
ing blood glucose, urea, creatinine, CHOL, TRIG and 
LDL-C after 9-10 years of  treatment were 2%, 0%, 2%, 
0%, 0% and 2%, respectively compared with 16%, 2%, 
14%, 5%, 1% and 16%, respectively after 5-6 years of  
treatment (Figure 5). 
African Health Sciences Vol 18 Issue 4, December, 2018 904
 
 
Figure 5. Percentage of diabetics presenting with high levels of measured  
parameters based on treatment duration. The percentage of diabetics with  
high levels of measured indices decreased after 5-6 years of treatment. 
Discussion
The significantly higher plasma creatinine and urea lev-
els in diabetics compared to controls are in agreement 
with previous findings which revealed the existence of  a 
strong positive relationship between blood sugar level and 
urea level19-21. Plasma creatinine and urea are established 
markers of  glomerular filtration with plasma creatinine 
being more sensitive index of  kidney function. All renal 
cell types including glomerular podocytes, mesangial and 
endothelial cells, tubular epithelial cells, interstitial fibro-
blasts, and vascular endothelia may be affected by hyper-
glycaemic injury and this may explain the increase in urea 
and creatinine levels in the blood alongside chronic hy-
perglycemia22-24. It has been reported that females with 
type 2 diabetes mellitus have a higher risk of  renal dys-
function than males25,26. However, other studies report-
ed a higher risk of  renal dysfunction in type 2 diabetic 
males25,27.  In the present study, female diabetics were 
found to have higher urea and creatinine levels than their 
male counterparts, an indication that the female diabetics 
have poorer kidney function than the male diabetics. This 
inconsistency was ascribed to the background character-
istics of  participants in the studies28. The plasma glucose 
and creatinine levels of  both male and female non-diabet-
ics in our study was similar to an earlier study, however, 
the urea levels in the earlier study was significantly higher 
than the present study21.
Altered lipid profile is a feature of  diabetes mellitus and 
dyslipidemia predisposes diabetic patients to cardiovas-
cular complications, especially coronary heart disease 
(CHD)29-31. The cause of  the greater relative risk of  CHD 
in diabetic women still remains incompletely understood. 
However, it has been reported that the adverse changes 
induced by T2DM in some cardiovascular risk factors, 
such as HDL-C, TRIG, LDL-C particle size and blood 
pressure have been found to be more pronounced in 
women than in men32,33. In the present study, a signifi-
cantly (p < 0.05) higher levels of  total cholesterol and 
LDL-C was observed in female diabetics when compared 
with their male counterparts. Moreover, a lower HDL-C 
level was also observed in diabetic females when com-
pared with their male diabetics. These observations are in 
consonance with an earlier study34. 
The LDL-C/HDL-C ratio and the CHOL/HDL-C ratio 
(atherogenic or Castelli index) are important components 
and indicators of  vascular risk with greater predictive 
value than the isolated parameters used independently, 
particularly LDL-C35. In the Helsinki Heart Study, it was 
demonstrated that the LDL-C:HDL-C ratio paints the 
most relevant picture of  a person’s cardiovascular health 
risk especially when triglyceridaemia is taken into account 
and the risk is significantly higher in the presence of  hy-
pertriglyceridaemia36.  In our study, diabetics had a higher 
(P < 0.0001) LDL-C/HDL-C ratio when compared with 
the controls. According to previous workers, the risk level 
of  LDL-C/HDL-C is >3.5 for men and >3.0 for women, 
while the target level for both men and women are 3.0 
and 2.5, respectively in primary intervention. However, 
when there is no reliable calculation of  LDL-C, especially 
when triglyceridaemia exceeds 300 mg/dl (3.36 mmol/L), 
it is preferable to use the CHOL: HDL-C ratio. In the 
present study CHOL:HDL-C ratio of  6.28 and 3.88 were 
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observed in diabetics and controls, respectively. A risk 
level 5.0 for men and 4.5 for women and a target lev-
el of  4.5 and 4.0 for men and women, respectively have 
been suggested37. The atherogenic index of  plasma (AIP) 
represented as log (TG/HDL-C) has been successfully 
used as an additional index when assessing cardiovascular 
risk factors38,39. It has been suggested that AIP values of  
-0.3 to 0.1, 0.1 to 0.24 and above 0.24 are associated with 
low, medium and high cardiovascular risk, respectively40. 
Healthy controls in our study had an appreciably lower 
and safe AIP value as against the value shown by dia-
betics. Multiple epidemiological studies have shown that 
these ratios have a greater correlation with cardiovascular 
disease and are therefore better predictors of  cardiovas-
cular disease than simple lipid parameters41,42.
Our study shows that the 50-59 age group had the highest 
percentage of  subjects that presented with derangements 
in most parameters evaluated in the study. This supports 
the generally known fact that the onset of  T2DM is usu-
ally after 40 years although younger people are increasing-
ly being diagnosed with diabetes. Fasting blood glucose, 
creatinine, urea, TRIG, and LDL-C levels were higher in 
majority of  the subjects in this age group than others. This 
could imply that this age group is the period when most 
diabetics are first diagnosed as our result further showed 
that the percentage of  subjects that showed high levels 
of  these parameters in older age groups fell remarkably. 
This could be due to the fact that the older age groups 
have taken treatment for a relatively long time after being 
diagnosed with diabetes. This pattern is similar to the one 
observed in an earlier study where majority of  the sub-
jects in the diabetic group were in the age group of  50-59 
years43. These results are in agreement with earlier works 
which showed that age plays a significant role in the risk 
of  developing T2DM especially after 40 years44. However 
our result is at variance with Otamere et.al45 who report-
ed that neither the age of  the subjects nor the duration 
of  the diabetes significantly affected the level of  lipids. 
A similar lipid profile was observed between diabetics in 
our study and an earlier study, however, female diabetics 
in the present study had a higher triglyceride and LDL-C 
levels45.
The duration of  treatment with anti-diabetic drugs had a 
significant effect on the studied parameters. In the pres-
ent study, there was a marked decrease in the percentage 
of  subjects showing high levels of  fasting blood glucose, 
creatinine, urea, CHOL, LDL-C and triglyceride after re-
ceiving treatment for     7 years when compared with those 
who have received treatment for less than 7 years. This 
showed the beneficial effect of  long-term management 
(either through drugs and/or lifestyle modifications) of  
diabetics. Our observation is however in contrast with a 
previous study which reported an increase in serum cre-
atinine and urea with duration of  diabetes of  more than 
10 years with a higher percentage increase observed in 
females than males46.
Although there have been several studies in which bio-
chemical indices were compared in normal and diabetic 
individuals, there is a dearth of  studies in which all the 
parameters investigated in this study were compared and 
to the best of  our knowledge, no similar study has been 
undertaken in Ekiti State, Nigeria. 
This study indicated that more gender specific modalities 
for managing type 2 diabetes is desirable as female type 2 
diabetes patients undergoing treatment at EKSUTH gen-
erally showed worse renal function and more deranged 
lipid profile than their male counterparts. While this study 
showed that dysregulated metabolic and lipid profiles are 
more prevalent in type 2 diabetics in the 50-59 age group, 
consistent management of  the condition is necessary at 
all age groups, as long term management of  the disease 
seems to be very beneficial.
 
Limitations of  the study
This study was conducted in a tertiary health centre locat-
ed in an urban environment. This explains why most of  
the subjects were relatively literate and are also aware of  
the importance of  conventional medications for manag-
ing their conditions. In addition, the number of  subjects 
could have been more and equal numbers of  controls 
and diabetics, though desirable, were not used because 
the number of  available patients that met the inclusion 
and exclusion criteria for diabetics and controls were dif-
ferent. It is however believed that better understanding 
of  the effects of  gender, age and treatment duration of  
type 2 diabetes would be more apparent if  similar studies 
including more participants from sub-tertiary health cen-
tres are conducted over a wider area.
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